Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss).
This report offers an overview of the market trends, drivers, and barriers with respect to the China Alzheimer's Disease market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Alzheimer's Disease market. Detailed analysis of key players, along with key growth strategies adopted by Alzheimer's Disease industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Merz Pharma
Johnson & Johnson
Lundbeck
Daiichi Sankyo
Allergan
Eisai
Pfizer
Novartis
By Type:
Donepezil
Memantine
Rivastigmine
By End-User:
Early to Moderate Stages
Moderate to Severe Stages
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Alzheimer's Disease Market
-
1.3 Market Segment by Type
-
1.3.1 China Alzheimer's Disease Market Size and Growth Rate of Donepezil from 2016 to 2027
-
1.3.2 China Alzheimer's Disease Market Size and Growth Rate of Memantine from 2016 to 2027
-
1.3.3 China Alzheimer's Disease Market Size and Growth Rate of Rivastigmine from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Alzheimer's Disease Market Size and Growth Rate of Early to Moderate Stages from 2016 to 2027
-
1.4.2 China Alzheimer's Disease Market Size and Growth Rate of Moderate to Severe Stages from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Alzheimer's Disease Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Alzheimer's Disease by Major Types
-
3.4.1 Market Size and Growth Rate of Donepezil
-
3.4.2 Market Size and Growth Rate of Memantine
-
3.4.3 Market Size and Growth Rate of Rivastigmine
4 Segmentation of Alzheimer's Disease Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Alzheimer's Disease by Major End-Users
-
4.4.1 Market Size and Growth Rate of Alzheimer's Disease in Early to Moderate Stages
-
4.4.2 Market Size and Growth Rate of Alzheimer's Disease in Moderate to Severe Stages
5 Market Analysis by Regions
-
5.1 China Alzheimer's Disease Production Analysis by Regions
-
5.2 China Alzheimer's Disease Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Alzheimer's Disease Landscape Analysis
-
6.1 North China Alzheimer's Disease Landscape Analysis by Major Types
-
6.2 North China Alzheimer's Disease Landscape Analysis by Major End-Users
7 Central China Alzheimer's Disease Landscape Analysis
-
7.1 Central China Alzheimer's Disease Landscape Analysis by Major Types
-
7.2 Central China Alzheimer's Disease Landscape Analysis by Major End-Users
8 South China Alzheimer's Disease Landscape Analysis
-
8.1 South China Alzheimer's Disease Landscape Analysis by Major Types
-
8.2 South China Alzheimer's Disease Landscape Analysis by Major End-Users
9 East China Alzheimer's Disease Landscape Analysis
-
9.1 East China Alzheimer's Disease Landscape Analysis by Major Types
-
9.2 East China Alzheimer's Disease Landscape Analysis by Major End-Users
10 Northeast China Alzheimer's Disease Landscape Analysis
-
10.1 Northeast China Alzheimer's Disease Landscape Analysis by Major Types
-
10.2 Northeast China Alzheimer's Disease Landscape Analysis by Major End-Users
11 Southwest China Alzheimer's Disease Landscape Analysis
-
11.1 Southwest China Alzheimer's Disease Landscape Analysis by Major Types
-
11.2 Southwest China Alzheimer's Disease Landscape Analysis by Major End-Users
12 Northwest China Alzheimer's Disease Landscape Analysis
-
12.1 Northwest China Alzheimer's Disease Landscape Analysis by Major Types
-
12.2 Northwest China Alzheimer's Disease Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Merz Pharma
-
13.1.1 Merz Pharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Johnson & Johnson
-
13.2.1 Johnson & Johnson Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Lundbeck
-
13.3.1 Lundbeck Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Daiichi Sankyo
-
13.4.1 Daiichi Sankyo Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Allergan
-
13.5.1 Allergan Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Eisai
-
13.6.1 Eisai Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Pfizer
-
13.7.1 Pfizer Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Novartis
-
13.8.1 Novartis Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Alzheimer's Disease Market Size and Growth Rate of Donepezil from 2016 to 2027
-
Figure China Alzheimer's Disease Market Size and Growth Rate of Memantine from 2016 to 2027
-
Figure China Alzheimer's Disease Market Size and Growth Rate of Rivastigmine from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Alzheimer's Disease Market Size and Growth Rate of Early to Moderate Stages from 2016 to 2027
-
Figure China Alzheimer's Disease Market Size and Growth Rate of Moderate to Severe Stages from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Alzheimer's Disease Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Alzheimer's Disease Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Alzheimer's Disease
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Alzheimer's Disease by Different Types from 2016 to 2027
-
Table Consumption Share of Alzheimer's Disease by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Donepezil
-
Figure Market Size and Growth Rate of Memantine
-
Figure Market Size and Growth Rate of Rivastigmine
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Alzheimer's Disease by Different End-Users from 2016 to 2027
-
Table Consumption Share of Alzheimer's Disease by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Early to Moderate Stages
-
Figure Market Size and Growth Rate of Moderate to Severe Stages
-
Table China Alzheimer's Disease Production by Regions
-
Table China Alzheimer's Disease Production Share by Regions
-
Figure China Alzheimer's Disease Production Share by Regions in 2016
-
Figure China Alzheimer's Disease Production Share by Regions in 2021
-
Figure China Alzheimer's Disease Production Share by Regions in 2027
-
Table China Alzheimer's Disease Consumption by Regions
-
Table China Alzheimer's Disease Consumption Share by Regions
-
Figure China Alzheimer's Disease Consumption Share by Regions in 2016
-
Figure China Alzheimer's Disease Consumption Share by Regions in 2021
-
Figure China Alzheimer's Disease Consumption Share by Regions in 2027
-
Table North China Alzheimer's Disease Consumption by Types from 2016 to 2027
-
Table North China Alzheimer's Disease Consumption Share by Types from 2016 to 2027
-
Figure North China Alzheimer's Disease Consumption Share by Types in 2016
-
Figure North China Alzheimer's Disease Consumption Share by Types in 2021
-
Figure North China Alzheimer's Disease Consumption Share by Types in 2027
-
Table North China Alzheimer's Disease Consumption by End-Users from 2016 to 2027
-
Table North China Alzheimer's Disease Consumption Share by End-Users from 2016 to 2027
-
Figure North China Alzheimer's Disease Consumption Share by End-Users in 2016
-
Figure North China Alzheimer's Disease Consumption Share by End-Users in 2021
-
Figure North China Alzheimer's Disease Consumption Share by End-Users in 2027
-
Table Central China Alzheimer's Disease Consumption by Types from 2016 to 2027
-
Table Central China Alzheimer's Disease Consumption Share by Types from 2016 to 2027
-
Figure Central China Alzheimer's Disease Consumption Share by Types in 2016
-
Figure Central China Alzheimer's Disease Consumption Share by Types in 2021
-
Figure Central China Alzheimer's Disease Consumption Share by Types in 2027
-
Table Central China Alzheimer's Disease Consumption by End-Users from 2016 to 2027
-
Table Central China Alzheimer's Disease Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Alzheimer's Disease Consumption Share by End-Users in 2016
-
Figure Central China Alzheimer's Disease Consumption Share by End-Users in 2021
-
Figure Central China Alzheimer's Disease Consumption Share by End-Users in 2027
-
Table South China Alzheimer's Disease Consumption by Types from 2016 to 2027
-
Table South China Alzheimer's Disease Consumption Share by Types from 2016 to 2027
-
Figure South China Alzheimer's Disease Consumption Share by Types in 2016
-
Figure South China Alzheimer's Disease Consumption Share by Types in 2021
-
Figure South China Alzheimer's Disease Consumption Share by Types in 2027
-
Table South China Alzheimer's Disease Consumption by End-Users from 2016 to 2027
-
Table South China Alzheimer's Disease Consumption Share by End-Users from 2016 to 2027
-
Figure South China Alzheimer's Disease Consumption Share by End-Users in 2016
-
Figure South China Alzheimer's Disease Consumption Share by End-Users in 2021
-
Figure South China Alzheimer's Disease Consumption Share by End-Users in 2027
-
Table East China Alzheimer's Disease Consumption by Types from 2016 to 2027
-
Table East China Alzheimer's Disease Consumption Share by Types from 2016 to 2027
-
Figure East China Alzheimer's Disease Consumption Share by Types in 2016
-
Figure East China Alzheimer's Disease Consumption Share by Types in 2021
-
Figure East China Alzheimer's Disease Consumption Share by Types in 2027
-
Table East China Alzheimer's Disease Consumption by End-Users from 2016 to 2027
-
Table East China Alzheimer's Disease Consumption Share by End-Users from 2016 to 2027
-
Figure East China Alzheimer's Disease Consumption Share by End-Users in 2016
-
Figure East China Alzheimer's Disease Consumption Share by End-Users in 2021
-
Figure East China Alzheimer's Disease Consumption Share by End-Users in 2027
-
Table Northeast China Alzheimer's Disease Consumption by Types from 2016 to 2027
-
Table Northeast China Alzheimer's Disease Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Alzheimer's Disease Consumption Share by Types in 2016
-
Figure Northeast China Alzheimer's Disease Consumption Share by Types in 2021
-
Figure Northeast China Alzheimer's Disease Consumption Share by Types in 2027
-
Table Northeast China Alzheimer's Disease Consumption by End-Users from 2016 to 2027
-
Table Northeast China Alzheimer's Disease Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Alzheimer's Disease Consumption Share by End-Users in 2016
-
Figure Northeast China Alzheimer's Disease Consumption Share by End-Users in 2021
-
Figure Northeast China Alzheimer's Disease Consumption Share by End-Users in 2027
-
Table Southwest China Alzheimer's Disease Consumption by Types from 2016 to 2027
-
Table Southwest China Alzheimer's Disease Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Alzheimer's Disease Consumption Share by Types in 2016
-
Figure Southwest China Alzheimer's Disease Consumption Share by Types in 2021
-
Figure Southwest China Alzheimer's Disease Consumption Share by Types in 2027
-
Table Southwest China Alzheimer's Disease Consumption by End-Users from 2016 to 2027
-
Table Southwest China Alzheimer's Disease Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Alzheimer's Disease Consumption Share by End-Users in 2016
-
Figure Southwest China Alzheimer's Disease Consumption Share by End-Users in 2021
-
Figure Southwest China Alzheimer's Disease Consumption Share by End-Users in 2027
-
Table Northwest China Alzheimer's Disease Consumption by Types from 2016 to 2027
-
Table Northwest China Alzheimer's Disease Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Alzheimer's Disease Consumption Share by Types in 2016
-
Figure Northwest China Alzheimer's Disease Consumption Share by Types in 2021
-
Figure Northwest China Alzheimer's Disease Consumption Share by Types in 2027
-
Table Northwest China Alzheimer's Disease Consumption by End-Users from 2016 to 2027
-
Table Northwest China Alzheimer's Disease Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Alzheimer's Disease Consumption Share by End-Users in 2016
-
Figure Northwest China Alzheimer's Disease Consumption Share by End-Users in 2021
-
Figure Northwest China Alzheimer's Disease Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Merz Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma
-
Figure Sales and Growth Rate Analysis of Merz Pharma
-
Figure Revenue and Market Share Analysis of Merz Pharma
-
Table Product and Service Introduction of Merz Pharma
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Lundbeck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lundbeck
-
Figure Sales and Growth Rate Analysis of Lundbeck
-
Figure Revenue and Market Share Analysis of Lundbeck
-
Table Product and Service Introduction of Lundbeck
-
Table Company Profile and Development Status of Daiichi Sankyo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo
-
Table Product and Service Introduction of Daiichi Sankyo
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Eisai
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai
-
Figure Sales and Growth Rate Analysis of Eisai
-
Figure Revenue and Market Share Analysis of Eisai
-
Table Product and Service Introduction of Eisai
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
